JP2012508027A5 - - Google Patents

Info

Publication number

JP2012508027A5

JP2012508027A5 JP2011535765A JP2011535765A JP2012508027A5 JP 2012508027 A5 JP2012508027 A5 JP 2012508027A5 JP 2011535765 A JP2011535765 A JP 2011535765A JP 2011535765 A JP2011535765 A JP 2011535765A JP 2012508027 A5 JP2012508027 A5 JP 2012508027A5

Authority

JP

Japan

Prior art keywords

cadherin

seq

diabody

cells

antibody

Prior art date

2009-11-10

Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)

Pending

Links

• Espacenet
• Global Dossier
• Discuss

• 102000000905 Cadherin Human genes 0.000 description 26
• 108050007957 Cadherin Proteins 0.000 description 26
• 108050000637 N-cadherin Proteins 0.000 description 24
• 210000004027 cell Anatomy 0.000 description 13
• 206010028980 Neoplasm Diseases 0.000 description 10
• 150000007523 nucleic acids Chemical class 0.000 description 8
• 108020004707 nucleic acids Proteins 0.000 description 7
• 102000039446 nucleic acids Human genes 0.000 description 7
• 125000003275 alpha amino acid group Chemical group 0.000 description 6
• 230000027455 binding Effects 0.000 description 5
• 108090000623 proteins and genes Proteins 0.000 description 5
• 102000004169 proteins and genes Human genes 0.000 description 5
• 201000011510 cancer Diseases 0.000 description 4
• 238000000034 method Methods 0.000 description 4
• 241000894006 Bacteria Species 0.000 description 3
• 102000008394 Immunoglobulin Fragments Human genes 0.000 description 3
• 108010021625 Immunoglobulin Fragments Proteins 0.000 description 3
• 102000007056 Recombinant Fusion Proteins Human genes 0.000 description 3
• 108010008281 Recombinant Fusion Proteins Proteins 0.000 description 3
• 238000000684 flow cytometry Methods 0.000 description 3
• 239000012634 fragment Substances 0.000 description 3
• 108020004999 messenger RNA Proteins 0.000 description 3
• 238000004091 panning Methods 0.000 description 3
• 229920001184 polypeptide Polymers 0.000 description 3
• 102000004196 processed proteins & peptides Human genes 0.000 description 3
• 108090000765 processed proteins & peptides Proteins 0.000 description 3
• 238000010186 staining Methods 0.000 description 3
• 238000002965 ELISA Methods 0.000 description 2
• 241000124008 Mammalia Species 0.000 description 2
• 150000001413 amino acids Chemical class 0.000 description 2
• 239000002299 complementary DNA Substances 0.000 description 2
• 238000001943 fluorescence-activated cell sorting Methods 0.000 description 2
• 230000004807 localization Effects 0.000 description 2
• -1 nucleotides Nucleic acids Chemical class 0.000 description 2
• 239000013598 vector Substances 0.000 description 2
• FWMNVWWHGCHHJJ-SKKKGAJSSA-N 4-amino-1-[(2r)-6-amino-2-[[(2r)-2-[[(2r)-2-[[(2r)-2-amino-3-phenylpropanoyl]amino]-3-phenylpropanoyl]amino]-4-methylpentanoyl]amino]hexanoyl]piperidine-4-carboxylic acid Chemical compound C([C@H](C(=O)N[C@H](CC(C)C)C(=O)N[C@H](CCCCN)C(=O)N1CCC(N)(CC1)C(O)=O)NC(=O)[C@H](N)CC=1C=CC=CC=1)C1=CC=CC=C1 FWMNVWWHGCHHJJ-SKKKGAJSSA-N 0.000 description 1
• 108700028369 Alleles Proteins 0.000 description 1
• 241000699800 Cricetinae Species 0.000 description 1
• 101000714537 Homo sapiens Cadherin-2 Proteins 0.000 description 1
• 108091028043 Nucleic acid sequence Proteins 0.000 description 1
• 108091005461 Nucleic proteins Proteins 0.000 description 1
• 241001494479 Pecora Species 0.000 description 1
• 241000288906 Primates Species 0.000 description 1
• 206010060862 Prostate cancer Diseases 0.000 description 1
• 208000000236 Prostatic Neoplasms Diseases 0.000 description 1
• 241000283984 Rodentia Species 0.000 description 1
• 108010090804 Streptavidin Proteins 0.000 description 1
• 230000001580 bacterial effect Effects 0.000 description 1
• 229960002685 biotin Drugs 0.000 description 1
• 239000011616 biotin Substances 0.000 description 1
• 239000004568 cement Substances 0.000 description 1
• 238000012512 characterization method Methods 0.000 description 1
• 238000004587 chromatography analysis Methods 0.000 description 1
• 239000012141 concentrate Substances 0.000 description 1
• HNDVDQJCIGZPNO-UHFFFAOYSA-N histidine Natural products OC(=O)C(N)CC1=CN=CN1 HNDVDQJCIGZPNO-UHFFFAOYSA-N 0.000 description 1
• 102000048721 human CDH2 Human genes 0.000 description 1
• 238000009396 hybridization Methods 0.000 description 1
• 230000003053 immunization Effects 0.000 description 1
• 238000002649 immunization Methods 0.000 description 1
• 230000002163 immunogen Effects 0.000 description 1
• 230000006698 induction Effects 0.000 description 1
• 208000015181 infectious disease Diseases 0.000 description 1
• 238000002347 injection Methods 0.000 description 1
• 239000007924 injection Substances 0.000 description 1
• 238000002955 isolation Methods 0.000 description 1
• BPHPUYQFMNQIOC-NXRLNHOXSA-N isopropyl beta-D-thiogalactopyranoside Chemical compound CC(C)S[C@@H]1O[C@H](CO)[C@H](O)[C@H](O)[C@H]1O BPHPUYQFMNQIOC-NXRLNHOXSA-N 0.000 description 1
• 239000000463 material Substances 0.000 description 1
• 239000002773 nucleotide Substances 0.000 description 1
• 108091033319 polynucleotide Proteins 0.000 description 1
• 102000040430 polynucleotide Human genes 0.000 description 1
• 239000002157 polynucleotide Substances 0.000 description 1
• 210000005267 prostate cell Anatomy 0.000 description 1
• 238000000746 purification Methods 0.000 description 1
• 238000003757 reverse transcription PCR Methods 0.000 description 1
• 230000011664 signaling Effects 0.000 description 1
• 238000002415 sodium dodecyl sulfate polyacrylamide gel electrophoresis Methods 0.000 description 1
• 230000009870 specific binding Effects 0.000 description 1
• 210000000130 stem cell Anatomy 0.000 description 1
• 230000004614 tumor growth Effects 0.000 description 1